These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 21881770)

  • 21. [The current status of the resistance of malaria pathogens to antimalarials].
    Kondrashin AV; Baranova AM; Morozov EN; Morozova LF; Stepanova EV
    Med Parazitol (Mosk); 2014; (3):51-7. PubMed ID: 25286554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular and biological aspects of antimalarial resistance in Plasmodium falciparum and Plasmodium vivax.
    Bustamante C; Batista CN; Zalis M
    Curr Drug Targets; 2009 Mar; 10(3):279-90. PubMed ID: 19275564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monitoring the efficacy of antimalarial medicines in India via sentinel sites: Outcomes and risk factors for treatment failure.
    Mishra N; Srivastava B; Bharti RS; Rana R; Kaitholia K; Anvikar AR; Das MK; Ghosh SK; Bhatt RM; Tyagi PK; Dev V; Phookan S; Wattal SL; Sonal GS; Dhariwal AC; Valecha N
    J Vector Borne Dis; 2016; 53(2):168-78. PubMed ID: 27353588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Does the brief treatment with antimalarials favorably influence drug resistance and recurrences?].
    Kroeger A
    Rev Panam Salud Publica; 2001 Mar; 9(3):202-4. PubMed ID: 11349355
    [No Abstract]   [Full Text] [Related]  

  • 25. [The proper use of antimalarial drugs currently available].
    Bourgeade A; Delmont J
    Bull Soc Pathol Exot; 1998; 91(5 Pt 1-2):493-6. PubMed ID: 10078393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blood-stage dynamics and clinical implications of mixed Plasmodium vivax-Plasmodium falciparum infections.
    Mason DP; McKenzie FE
    Am J Trop Med Hyg; 1999 Sep; 61(3):367-74. PubMed ID: 10497972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Haematological response in experimental human Plasmodium falciparum and Plasmodium vivax malaria.
    Woolley SD; Marquart L; Woodford J; Chalon S; Moehrle JJ; McCarthy JS; Barber BE
    Malar J; 2021 Dec; 20(1):470. PubMed ID: 34930260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Artemisinin combination therapy for vivax malaria.
    Douglas NM; Anstey NM; Angus BJ; Nosten F; Price RN
    Lancet Infect Dis; 2010 Jun; 10(6):405-16. PubMed ID: 20510281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversal of Chloroquine Resistance of Plasmodium vivax in Aotus Monkeys.
    Obaldia N; Milhous WK; Kyle DE
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29941642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stronger activity of human immunodeficiency virus type 1 protease inhibitors against clinical isolates of Plasmodium vivax than against those of P. falciparum.
    Lek-Uthai U; Suwanarusk R; Ruengweerayut R; Skinner-Adams TS; Nosten F; Gardiner DL; Boonma P; Piera KA; Andrews KT; Machunter B; McCarthy JS; Anstey NM; Price RN; Russell B
    Antimicrob Agents Chemother; 2008 Jul; 52(7):2435-41. PubMed ID: 18443130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Malaria Elimination: Time to Target All Species.
    Lover AA; Baird JK; Gosling R; Price RN
    Am J Trop Med Hyg; 2018 Jul; 99(1):17-23. PubMed ID: 29761762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can estimates of antimalarial efficacy from field studies be improved?
    Gatton ML; Cheng Q
    Trends Parasitol; 2008 Feb; 24(2):68-73. PubMed ID: 18182325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monitoring the chloroquine sensitivity of Plasmodium vivax from Calcutta and Orissa, India.
    Nandy A; Addy M; Maji AK; Bandyopadhyay AK
    Ann Trop Med Parasitol; 2003 Apr; 97(3):215-20. PubMed ID: 12803853
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    McCallum FJ; Birrell GW; Chavchich M; Harris I; Obaldia N; Van Breda K; Heffernan GD; Jacobus DP; Shanks D; Edstein MD
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31843994
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasmodium vivax in the Era of the Shrinking P. falciparum Map.
    Price RN; Commons RJ; Battle KE; Thriemer K; Mendis K
    Trends Parasitol; 2020 Jun; 36(6):560-570. PubMed ID: 32407682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proteomic approaches to studying drug targets and resistance in Plasmodium.
    Cooper RA; Carucci DJ
    Curr Drug Targets Infect Disord; 2004 Mar; 4(1):41-51. PubMed ID: 15032633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo sulphadoxine-pyrimethamine sentitivity study Tigray Region, Southern Zone, Alamata Town, September--November 2001.
    Degefa T
    Ethiop Med J; 2004 Jan; 42(1):35-9. PubMed ID: 15884275
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Azithromycin-chloroquine and the intermittent preventive treatment of malaria in pregnancy.
    Chico RM; Pittrof R; Greenwood B; Chandramohan D
    Malar J; 2008 Dec; 7():255. PubMed ID: 19087267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular markers of anti-malarial drug resistance in southwest Ethiopia over time: regional surveillance from 2006 to 2013.
    Heuchert A; Abduselam N; Zeynudin A; Eshetu T; Löscher T; Wieser A; Pritsch M; Berens-Riha N
    Malar J; 2015 May; 14():208. PubMed ID: 25986047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of malaria in Aligarh.
    Mehrunnisa A; Wajihullah ; Saifi MA; Khan HM
    J Commun Dis; 2002 Mar; 34(1):70-7. PubMed ID: 12718345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.